Personal information

Keywords

Natural Product Chemistry, High Content Screening, Drug Discovery, Cancer, Microbiology

Biography

My research interests lie in natural product chemistry and drug discovery. During my PhD I was working on natural product isolation and elucidation, as well as establishing a high-content screen to discover compounds inhibiting melanoma. I am very interested in natural product biosynthesis and chemical ecology to gain a deeper understanding of the source and the reason of natural product production.

Activities

Collapse all

Employment (6)

University of California, San Diego: San Diego, US

2023-07-01 to 2025-06-30 | Postdoc (CMBB)
Employment
Source: Self-asserted source
Lara Dürr

Sanofi (Switzerland): Vernier, CH

2022-07-01 to 2023-06-30 | Brandmanager (Marketing Rotkreuz)
Employment
Source: Self-asserted source
Lara Dürr

University of Basel: Basel, Basel-Stadt, CH

2017-08-15 to 2022-05-31 | PhD Student and assistant (Pharmaceutical Sciences)
Employment
Source: Self-asserted source
Lara Dürr

Evolva Holding SA: Reinach, Basel-Stadt, CH

2017-01-04 to 2017-06-30 | Internship
Employment
Source: Self-asserted source
Lara Dürr

University of Bergen: Bergen, Hordaland, NO

2016-09-05 to 2016-10-14 | IAESTE Internship (Molecular Biology)
Employment
Source: Self-asserted source
Lara Dürr

University of Basel: Basel, Basel-Stadt, CH

2016-03-01 to 2016-08-31 | Internship (Biozentrum)
Employment
Source: Self-asserted source
Lara Dürr

Education and qualifications (2)

University of Basel: Basel, Basel-Stadt, CH

2014-09-01 to 2016-02-28 | Master of Science, Major in Microbiology (Biozentrum)
Education
Source: Self-asserted source
Lara Dürr

University of Basel: Basel, Basel-Stadt, CH

2011-09-01 to 2014-06-30 | Bachelor in Molecular Biology
Education
Source: Self-asserted source
Lara Dürr

Professional activities (1)

Swiss Chemical Society: Bern, Bern, CH

Membership
Source: Self-asserted source
Lara Dürr

Works (6)

Flavonoids from Ericameria nauseosa inhibiting PI3K/AKT pathway in human melanoma cells

Biomedicine & Pharmacotherapy
2022-12 | Journal article
DOI: 10.1016/j.biopha.2022.113754
Part of ISSN: 0753-3322
Contributors: Lara Dürr
Source: Self-asserted source
Lara Dürr

A Dimerosesquiterpene and Sesquiterpene Lactones from Artemisia argyi Inhibiting Oncogenic PI3K/AKT Signaling in Melanoma Cells

Journal of Natural Products
2022-11-25 | Journal article
DOI: 10.1021/acs.jnatprod.2c00471
Contributors: Lara Dürr; Jakob K. Reinhardt; Maciej Dobrzyński; Tanja Hell; Martin Smieško; Olivier Pertz; Matthias Hamburger; Eliane Garo
Source: check_circle
Crossref

Combining Activity Profiling with Advanced Annotation to Accelerate the Discovery of Natural Products Targeting Oncogenic Signaling in Melanoma

Journal of Natural Products
2022-05-31 | Journal article
DOI: 10.1021/acs.jnatprod.2c00146
Part of ISSN: 0163-3864
Part of ISSN: 1520-6025
Source: Self-asserted source
Lara Dürr
grade
Preferred source (of 2)‎

High-Content Screening Pipeline for Natural Products Targeting Oncogenic Signaling in Melanoma

Journal of Natural Products
2022-03-01 | Journal article
DOI: 10.1021/acs.jnatprod.1c01154
Part of ISSN: 0163-3864
Part of ISSN: 1520-6025
Source: Self-asserted source
Lara Dürr

DNA Uptake upon T6SS-Dependent Prey Cell Lysis Induces SOS Response and Reduces Fitness of Acinetobacter baylyi.

Cell reports
2019-11-01 | Journal article
Part of DOI: 10.1016/j.celrep.2019.09.083
PMID: 31693901
Source: Self-asserted source
Lara Dürr

De novo biosynthesis of anthocyanins in Saccharomyces cerevisiae.

FEMS yeast research
2018-06-01 | Journal article
Part of DOI: 10.1093/femsyr/foy046
PMID: 29771352
Source: Self-asserted source
Lara Dürr
How many people are using ORCID?